Global Database of CAR-T Cell Therapy Companies, 2023
CAR-T cell therapy is a remarkably promising treatment for cancer patients.
Since the first historic CAR-T approvals in 2017, the following products have been approved by the U.S. FDA:
Kymriah /Yescarta/ Tecartus /Breyanzi /Abecma /Carvykti
These historic approvals have driven the CAR-T market to staggering new heights and fueled a frenzy of interest into CAR-T cell therapy development. To track the competitors who compose this rapidly expanding market, BioInformant has released a global database of all known CAR-T cell therapy companies—currently 191 worldwide.
We originally developed this database for our own purposes, but more and more of our readers have requested access to it.
CAR-T Company Database
This database features the following information for all known CAR-T market competitors:
Company Name
CAR-T Technology
Disease Targets
Description of CAR-T Involvement
Country
City / State
Link to CAR-T Programs
Company Website
Use this searchable database of CAR-T companies to:
Identify global competitors within the CAR-T marketplace
Quantify CAR-T products in late-stage development
Reveal preclinical and clinical programs supporting CAR-T development
Identify potential partners and collaborators
It takes our team of analysts hours of research to uncover these CAR-T cell therapy companies from across the globe and requires the translation of sites and clinical trial programs across dozens of languages.
Thankfully, we have a talented, multilingual team who is up to the task of organizing all known CAR-T companies worldwide. Because we continuously update this database to reflect new competitors entering the CAR-T cell therapy marketplace, we are confident that you will find it to be invaluable resource.
ارسال به دوستان